A totally synthetic vaccine of generic structure that targets TLR2+ dendritic cells and promotes either antibody or CTL responses Journal Articles Refereed uri icon

Overview

Published in

  • Proceedings of the National Academy of Sciences of the United States of America

Time

Date/time value

  • 2004

Identity

Digital Object Identifier (DOI)

  • 10.1073/pnas.0406740101

Additional Document Info

Parent Title

  • Proceedings of the National Academy of Sciences of the United States of America

Volume

  • 101

Issue

  • 43

Publisher

  • National Academy of Sciences